Shengtao Dong
Overview
Explore the profile of Shengtao Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li W, Dong Y, Liu W, Tang Z, Sun C, Lowe S, et al.
Front Immunol
. 2022 Dec;
13:1003347.
PMID: 36466868
Osteosarcoma was the most frequent type of malignant primary bone tumor with a poor survival rate mainly occurring in children and adolescents. For precision treatment, an accurate individualized prognosis for...
2.
Xu C, Zhou Q, Liu W, Li W, Dong S, Li W, et al.
J Oncol
. 2022 Oct;
2022:5798602.
PMID: 36276292
Objective: To establish and verify the clinical prediction model of lung metastasis in renal cancer patients. Method: Kidney cancer patients from January 1, 2010, to December 31, 2017, in the...
3.
Li W, Jin G, Wu H, Wu R, Xu C, Wang B, et al.
Front Oncol
. 2022 Aug;
12:945362.
PMID: 36003782
Background: Currently, the clinical prediction model for patients with osteosarcoma was almost developed from single-center data, lacking external validation. Due to their low reliability and low predictive power, there were...
4.
Li W, Dong S, Lin Y, Wu H, Chen M, Qin C, et al.
BMC Cancer
. 2022 Aug;
22(1):914.
PMID: 35999524
Objective: The aim of this study was to establish and validate a clinical prediction model for assessing the risk of metastasis and patient survival in Ewing's sarcoma (ES). Methods: Patients...
5.
Li W, Wang G, Wu R, Dong S, Wang H, Xu C, et al.
Front Oncol
. 2022 Aug;
12:880305.
PMID: 35936720
Chondrosarcoma is a malignant bone tumor with a low incidence rate. Accurate risk evaluation is crucial for chondrosarcoma treatment. Due to the limited reliability of existing predictive models, we intended...
6.
Li W, Xu C, Hu Z, Dong S, Wang H, Liu Q, et al.
Front Public Health
. 2022 May;
10:877736.
PMID: 35602163
Background: This study aims to predict the lymphatic metastasis in Ewing's sarcoma (ES) patients by nomogram. The risk of lymphatic metastasis in patients with ES was predicted by the built...
7.
Li W, Liu W, Memon F, Wang B, Xu C, Dong S, et al.
Comput Intell Neurosci
. 2022 May;
2022:2220527.
PMID: 35571720
Background: Lung metastasis greatly affects medical therapeutic strategies in osteosarcoma. This study aimed to develop and validate a clinical prediction model to predict the risk of lung metastasis among osteosarcoma...
8.
Li W, Liu Y, Liu W, Tang Z, Dong S, Li W, et al.
Front Oncol
. 2022 May;
12:797103.
PMID: 35515104
Background: Regional lymph node metastasis is a contributor for poor prognosis in osteosarcoma. However, studies on risk factors for predicting regional lymph node metastasis in osteosarcoma are scarce. This study...
9.
Dong S, Li J, Jia X, Zhu J, Chen Y, Yuan B
Comput Intell Neurosci
. 2022 May;
2022:4745534.
PMID: 35498212
Background: Adjacent segment degeneration (ASD) has been considered as a serious complication from changes in the biological stress pattern after spinal fusion. The sagittal balance significantly associated with lumbar loading...
10.
Li W, Wang B, Dong S, Xu C, Song Y, Qiao X, et al.
Front Oncol
. 2022 Apr;
12:851552.
PMID: 35480102
Background: Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs)...